Summary
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees of β-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient β-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and β-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p < 0.0001), the fasting insulin concentration (Rs = 0.81, p < 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p < 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient β-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p < 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p < 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for β-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Holman RR, Turner RC (1979) Maintenance of basal plasma glucose and insulin concentration in maturity-onset diabetes. Diabetes 28: 227–230
Holman RR, Turner RC (1980) The basal plasma glucose: a simple relevant index of maturity onset diabetes. Clin Endocrinol 14: 279–286
McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93–97
Turner RC, Holman RR (1976) Insulin rather than glucose homeostasis in the pathophysiology of diabetes. Lancet 1: 1272–1274
Turner RC, Holman RR, Matthews DR, Hockaday TDR, Peto J (1979) Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal insulin and glucose concentrations. Metabolism 28: 1086–1096
Turner RC, Matthews DR, Holman RR, Peto J (1982) Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes. Lancet: 596–598
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214–223
Olefsky JM (1979) The insulin receptor: its role in insulin resistance of obesity and diabetes. Diabetes 25: 1154–1161
Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC (1985) Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta cell function in man. Diabetologia 28: 401–411
World Health Organisation (1980) Expert Committee on Diabetes Mellitus. Technical Report Series 646. WHO, Geneva
Hosker JP, Burnett MA, Davies EG, Matthews DR, Rudenski AS, Turner RC (1984) atLoss of normal sigmoidal beta cell response curve to glucose in non-insulin-dependent diabetes. Diabetologia 27: 289 A
Ellis BW, Randall NJ, Becket AJ, Dudley HAF (1976) Continuous blood sampling and time series analysis. J Med Eng Technol 2: 195–199
Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1–4
Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308–309 A
Gambhir KK, Archer JA, Bradley CJ (1972) Characteristics of human erythrocyte insulin receptors. Diabetes 27: 701–708
Matthews DR, Naylor BA, Jones RG, Ward GM, Turner RC (1983) Pulsatile insulin secretion has a greater hypoglycaemic effect than continuous delivery. Diabetes 32: 617–621
Matthews DR, Lang DA, Burnett MA, Turner RC (1983) Control of pulsatile insulin secretion in man. Diabetologia 24: 231–237
Turner RC, Matthews DR (1984) Insulin secretion in Type I and Type 2 diabetes. Front Diabetes 4: 36–54
Bergman RN, Ider YZ, Bowden CR, Cobelli C (1979) Quantitative estimation of insulin sensitivity. Am J Physiol 236: E667-E677
Rubenstein A, Robbins D, Tager H, Blix P, Berganstal R, Given B, Kanazawa Y (1982) Clinical significance of circulating proinsulin and C-peptide In: Skyler JS (ed) Insulin update. Excerpta Medica, London, Amsterdam, pp 24–40
LeBlanc J, Tremblay A, Richard D, Nadeau A (1983) Daily variations of plasma glucose and insulin in physically trained and sedentary subjects. Metabolism 32: 552–557
Turner RC, Harris EA, Ounstead M, Ponsford C (1979) Two abnormalities of glucose-induced insulin secretion: dose-response characteristics and insulin sensitivity. Acta Endocrinol 92: 148–165
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matthews, D.R., Hosker, J.P., Rudenski, A.S. et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985). https://doi.org/10.1007/BF00280883
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00280883